Life-threatening hyponatremia following a low-iodine diet: A case report and review of all reported cases

Endocrine Practice

Volumn 17, Issue 5, 2011, Pages

  Al Nozha, Omar M ^a   Vautour, Line ^b,c   How, Jacques ^b,d  

^a TAIBAH UNIVERSITY   (Saudi Arabia)

^b MCGILL UNIVERSITY   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

^d MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLICLAZIDE; HYDROCHLOROTHIAZIDE; IODINE 131; LOSARTAN; RECOMBINANT THYROTROPIN; THIAZIDE DIURETIC AGENT;

AGED; ARTICLE; CASE REPORT; DIETARY INTAKE; DIZZINESS; DRUG UTILIZATION; FEMALE; HUMAN; HYPERTENSION; HYPONATREMIA; IODINE DIET; LYMPH NODE DISSECTION; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SODIUM BLOOD LEVEL; SODIUM RESTRICTION; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

AGED; DIET; FEMALE; HUMANS; HYPONATREMIA; IODINE; SODIUM; THYROID NEOPLASMS; THYROTROPIN;

EID: 80054067267     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11045.CR     Document Type: Article

References (12)

1. Pacak K, Eisenhofer G, Ahlman H, et al; International Symposium on Pheochromocytoma. Pheochromocytoma: Recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab. 2007;3:92-102.
2. Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: A contemporary view with implica-tions for physiology and medicine. Pharmacol Rev. 2004;56:331-349.
3. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: Which test is best? JAMA. 2002;287:1427-1434.
4. Eisenhofer G, Lenders JW, Linehan WM, Walther MM, Goldstein DS, Keiser HR. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med. 1999;340:1872-1879.
5. Sawka AM, Jaeschke R, Singh RJ, Young WF Jr. A comparison of biochemical tests for pheochromocy-toma: Measurement of fractionated plasma metaneph-rines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab. 2003;88:553-558.
6. Lenders JW, Keiser HR, Goldstein DS, et al. Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med. 1995;123:101-109.
7. Raber W, Raffesberg W, Bischof M, et al. Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch Intern Med. 2000; 160:2957-2963.
8. Unger N, Pitt C, Schmidt IL, et al. Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur J Endocrinol. 2006;154:409-417.
9. Gao YC, Lu HK, Luo QY, Chen LB, Ding Y, Zhu RS. Comparison of free plasma metanephrines enzyme immu-noassay with (131)I-MIBG scan in diagnosis of pheochro-mocytoma. Clin Exp Med. 2008;8:87-91.
10. Procopiou M, Finney H, Akker SA, et al. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors. Eur J Endocrinol. 2009;161:131-140.
11. Peaston RT, Graham KS, Chambers E, van der Molen JC, Ball S. Performance of fractionated plasma free meta-nephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma. Clin Chim Acta. 2010;411:546-552.
12. Unger N, Deutschbein T, Walz MK, Mann K, Petersenn S. The value of immunoassays for metanephrines in the biochemical diagnosis of pheochromocytomas. Horm Metab Res. 2009;41:676-679.